
Clinical Director Vasc & Endovasc Surg Care Hospital Hyderabad INDIA. Past President @Vascular_India Course Director @VascAnatCourse Past President @World_fvs
hyderabad
Joined July 2014
- Tweets2.9K
- Following656
- Followers832
- Likes6.9K
Okay this guy is wild. The pivot speed in insane. Wakes up everyday to tweet anything but facts.
Mr Deep. The science points do not hold up against your own material. Let me explain once more and I'm ready to do this until you stfu.
Your website says Temple is "tested by independent validations." This thread says proof will be added "over the years." Both cannot be true today. Cannot be!
You say proof goes whitepaper to preprint to peer review. Temple has published none of the three. The 60-person TD-NIRS study exists only as a number in interviews. Fact.
"No medical claim" does not match a product page that calls BrainFlow, a proxy for cerebral blood flow and you claiming a 7% rise in brain blood flow from inversion. Regulators classify by the claim, not by whether you call it fitness or AI bullshit.
If Entropy is the main point, then the flagship feature has ZERO published data and the secondary one has one unpublished study, and you are taking Rs 85,000 pre-orders on that. Do you want me to explain that again?
"Wait for user reviews" - bro. How do you know the actual reviews if people can't reliably understand what they are using??
And one last thing buddy, "Temple is not made for India" and "we don't expect more than 1% of sales here" ... Really? You raised Rs 493 crore from Indian investors, launched on an Indian podcast, put the device on PV Sindhu, opened pre-orders in India first and in rupees, and are now answering Indian doctors. You cannot build the launch on India and then tell India it is not the market the moment we asks a question. Disowned at the slightest hint of trouble. That's fake nationalism bro.
Waiting for your tweet tomorrow to explain further. Please don't add anymore features 🙏🏽
Hello everyone. Happy Diwali!
Thank you for your criticism, your support and your time over the last two days. Gives me much needed clarity on what we need to explain better:
1. Temple is not made for India. It’s made for the world. Please check pricing. We don’t expect any more than 1% of Temples being sold in India.
2. If you are upset that the pricing is too high, I am sorry. There’s a lot of work that went into Temple, and we priced it at what we think it’s worth. If you think its overpriced, you can wait for user reviews to decide if its worth your money.
3. Please do not support us because we are an Indian startup. We want to compete globally. We don’t need/want nationalist support. Support us if you want to support early innovation, which could help you live a better life, and will continue to add more proof to its science over the years.
4. There are different audiences which buy products at various levels of proof. Proof goes from whitepaper -> pre-print -> peer reviewed. You are free to sit on the fence until peer reviewed proof arrives. You are free to not believe it even then. Nobody is forcing you to buy. Making announcements is our right; and if we overclaim anywhere, we will inevitably fall into regulatory trouble everywhere in the world.
5. We didn’t make any medical claim. Doctors primarily see things from a medical lens, so they see every claim as a medical claim. I repeat – Temple is strictly a fitness + AI device, and we've made no medical claims. Temple is not proven to diagnose or prevent any disease. It doesn't do anything which replaces the need for you to see a doctor.
6. The main point of Temple is NOT Brain Flow. That’s what we just started Temple for, and studies on Brain Flow are the first ones getting out.
7. The main point of Temple is Entropy (I shared the HomeScreen of Temple three months ago with Entropy as the main thing). Our emails to our waitlisted users only talk about Entropy. We haven’t published anything on Entropy yet. We will. If you want to buy Temple before that, please do. If you don’t want to, don’t.
8. Roomdeaf AI is an expansion of the device’s capabilities, and our vision for Temple. It is not a pivot.
9. Social media is not the regulator for Temple. Wherever we need regulatory clearances, we will have them before we make any claim needing them.
10. I will post a detailed note on how we calculate Brain Flow, its uses, and most importantly, its limitations in a bit (tomorrow).
P C Gupta retweeted
Good morning. Deepinder Goyal is a liar.
It was always about the brain, even though he now claims it was not.
His scam was caught in January 2026 after which he started calling out doctors rudely at that time also. He mentioned he will show the science of brain flow, Entropy assessment by the device at the time.
A few months later, he showed screen shots of what he calls the device can measure, which others cannot, called Entropy - screen shots from his own team - which can be easily made using Claude. Still no working device based proof. Zero evidence of parameters measured to showcase Entropy.
Fast forward 10 months later, November 2026, he is still making the same claims, no new evidence, no real data other than what his company wrote on the website. The company website (temple.com) still promotes the device for cognitive health, brain tracking and entropy.
I and other clinical-scientists HAVE gone through everyy detail of science published on Temple here temple.com/science-and-resea… and none of it proves this device can measure what it claims. Yes, heart rate and blood flow to the scalp from the temporal artery. But nothing more - because there is no data.
Temple is a beautiful scam, built over the years using influencer network, paid celebrity collaboration (obviously all of these will be denied) and a false marketing to convince people that this device does more than any other device. It does not do anything beyond the basics. This is a global scam and the government regulators must assess the claims made before this becomes a circus show for the West. Guys like MKBHD and Mrwhosetheboss who can really do work on this will rip it apart - so go give them the device and not your local chamcha influencers.
P C Gupta retweeted
Rs 85,000. For a sticker that measures your face and calls it your brain.
I am a Cardiothoracic Surgeon. Every day I hold a human heart in my hands and I fight to keep blood flowing to the brain. So when I see a device that claims to measure BrainFlow from your temple, I cannot stay silent.
Because what Temple is measuring is not your brain. It is your scalp. And that difference is not small. That difference is everything.
Let me make it simple for you.
Put your finger on your temple. Feel that pulse.
That is your superficial temporal artery.
That artery is a branch of the EXTERNAL carotid artery. It sits OUTSIDE your skull. Its job is to supply blood to your scalp, your temple, your face, your ear.
Your brain does NOT run on this artery.
Your brain runs on the INTERNAL carotid arteries and the vertebral arteries. They go deep inside. They are protected by bone, by muscle, by dura.
So when someone tells you a sticker on your temple is measuring your BrainFlow, I have to ask - how?
Temple uses PPG. Photoplethysmography. The same light-based technology in your smartwatch.
It shines light into the skin and sees how much blood is moving under it. At the wrist, it measures the wrist. At the temple, it measures the temple.
It cannot magically see through skin, scalp, temporalis muscle, skull bone, meninges, and then tell you what is happening inside your cortex. Light does not work like that. If it did, we would not need MRI, CT angiography, transcranial Doppler, or invasive monitoring in cardiac and neurosurgery.
In the OT, when I want to know cerebral perfusion, I do not put a sticker on the temple. I rely on validated monitors, on blood pressure, on cardiac output, on cerebral oximetry that has been tested in thousands of patients.
Because brain blood flow is not the same as scalp blood flow.
When you are embarrassed, your face flushes. Your temporal artery dilates. Does that mean your brain just got smarter?
When you drink coffee, when you exercise, when you get angry, when you stand up from a chair - your scalp flow changes. Your brain flow, thankfully, stays remarkably stable because of autoregulation. That is how we survive.
So if scalp flow and brain flow move together during exercise, that does not prove you are measuring the brain. That just proves both went up because your heart is pumping harder.
This is what we call correlation without causation. And with only 23 healthy volunteers in an unpublished, company-funded preprint, that is not validation. That is a pilot study. In medicine, we do not sell a pilot study for Rs 85,000 ($904 USD).
And then there is this new word - Entropy. A score from 1 to 250 to tell you the cost of being alive.
I can tell you, there is no validated medical biomarker called Entropy that you can measure from your temple and use to predict ageing, longevity, or brain health.
Metabolic carts, VO2 max testing, lab-based calorimetry - these took decades of validation. You cannot replace them with a proprietary algorithm and call it a discovery.
Now, Mr. Goyal says - Temple is not a medical device, it is a wellness device.
Then why call it BrainFlow? Why talk about brain ageing? Why talk about gravity ageing hypothesis? Why talk about cerebral blood flow?
You cannot market like a medical breakthrough and then hide behind a wellness disclaimer when doctors ask for proof.
And the argument - If it does not work, people will return it in 14 days, so it cannot be a scam.
Sir, with respect, a patient cannot know in 14 days if his brain blood flow measurement is accurate. He has no gold standard at home to compare it with. He will see a number go up and down, he will feel reassured, he will think he is tracking his brain. That is exactly the danger.
A 14-day return policy is not peer review. Spending 30 million dollars is not peer review. Having a good reputation in food delivery is not peer review.
In medicine,we have a simple rule. First, do no harm. Second, prove it before you sell.
P C Gupta retweeted
A little more light, a little more laughter, and countless reasons to feel good!
This Deepavali, may every new beginning bring you closer to a healthier, happier tomorrow. Wishing you and your loved ones a festival filled with warmth, wellness and wonderful moments!
Happy Diwali from all of us at CARE Hospitals.
#HappyDiwali #FestivalOfLights #CAREHospitals #TransformingHealthcare
🤖 Made with AI
P C Gupta retweeted
My last and concluding post, a long read.
Any device, medical or wellness, must pass this test.
A measurement helps a person only if every link in this chain holds:
1. It measures something that matters to health.
2. The number tells a healthy person’s normal range from a risky one. That needs known cut-offs.
3. There is something you can do that changes it.
4. Changing it improves how you live or how long you live. The number has to be a cause, not just a sign.
5. That action isn’t already advised without measuring.
6. The benefit outweighs the cost, anxiety and false reassurance.
Now assume, for argument’s sake, that Temple really does measure blood flow to the brain. It doesn’t.
Here is how it fares.
1. Does it measure something that matters?
Brain blood flow matters in stroke, narrowed vessels and brain bleeds, and doctors measure it there. In a healthy person, the brain regulates its own flow tightly. A reading is a snapshot of that regulation. Temple’s own scientists also describe BrainFlow as a relative signal against your own baseline, not an absolute flow.
2. Does it tell normal from risky?
No cut-offs exist for healthy adults. Flow varies between people and within one person across a day, with blood pressure, CO2, caffeine, posture, exercise, sleep and age. Without a range, the number can’t say “you’re fine” or “see a doctor.”
3. Can you change it?
Yes. Exercise and sleep do, and those are good habits. The rest are tricks: lying down, over-breathing, extra CO2, hanging upside down. Changing a number isn’t the same as improving your health.
Take inversion, which Goyal’s team has promoted. They reported that six weeks of daily inversion-table use raised average brain blood flow by 7% and could “possibly nullify 10 years of loss.” But the number was measured by the device under test. A 7% shift is within what posture, breathing and caffeine alone move in a day. And no outcome was measured: no better thinking, less dementia or longer life.
4. Does changing it improve health?
Lower brain flow in old age is linked to higher mortality, but it’s an association. Temple’s own research page says the study doesn’t show that raising flow extends life. Fitter people have higher brain flow, so fitness and healthy vessels likely drive both. Low flow may be a marker of disease, not a lever. Pushing the number up with a trick is like holding a thermometer in hot tea: the reading changes, the person doesn’t.
5. Is the action already advised without measuring?
Whatever the reading, the advice is the same: exercise, sleep, control BP and sugar, don’t smoke, stay mentally active and connected. What would you do differently tomorrow because of this number? For an ordinary person, nothing.
6. Does the benefit outweigh the cost, anxiety and false reassurance?
The cost is Rs 85,000 and terms that disclaim the accuracy of the data. A normal reading doesn’t rule out disease, and a “bad” one may just be coffee or posture.
There is also a risk in chasing the number. Hanging upside down raises blood pressure and eye pressure, and is generally advised against in glaucoma, hypertension and heart disease. Many people have undiagnosed hypertension or glaucoma. Would you tell a 60-year-old to hang upside down daily to raise a wearable’s number? The brain benefit is unproven. The risk is real for some.
Verdict: even on the most generous assumption, the chain breaks at links 2, 4, 5 and 6.
That is not a health nor a wellness tracker tool. It’s an experiment you pay for.
Treat your body and mind as a temple. That’s free.
Thank you for reading.
Upgrade to an alien 👽 look. Of course, there are cheaper and better options to achieve this.
Pre-order at temple.com; first 10,000 orders never pay a subscription to use Temple.
P C Gupta retweeted
Goodmorning to you good people (not you Deepinder). Now that India has entered the commercial era of "scienceploitation", I would like to educate and inform the people on this topic, using one of Temple device's claims as an example.
This is long, but stay with me, you will really benefit.
But first, what is Scienceploitation?
It is a marketing and communication tactic where brands, influencers, or media outlets borrow or manipulate language from legitimate, emerging areas of science (such as stem cell research, the microbiome, or epigenetics) to promote unproven health, wellness, or beauty products and services.
The term was coined by @CaulfieldTim (I am honored to have known him and written an editorial with him in the BMJ), a professor of health law and policy at the University of Alberta.
Temple Device is your first boss battle against scienceploitation. Let me explain this using their own biggest claim - ENTROPY. Temple claims it measures Entropy.
What is entropy? In lay terms, entropy is a measure of how spread out, mixed up, or disorganized things naturally become over time. In human health, entropy can be a measure of disorder, wear and tear, and loss of organization in your body's cells, tissues, and organ systems.
Low Entropy = High Health (Order): A young, healthy body is in a state of low entropy. Your cells are communicating well, your DNA is intact, your proteins are folded properly, and your heartbeats have a smooth, adaptable rhythm.
High Entropy = Disease or Aging (Disorder): As entropy increases, biological "mess" builds up. Damaged DNA accumulates, proteins misfold, cells stop working right, and communication breaks down.
Aging is essentially a slow, natural rise in entropy. While conditions like cancer (uncontrolled, chaotic cell growth), neurodegeneration (like Alzheimer’s protein tangles), and metabolic dysfunction (like uncontrolled blood sugar) represent spikes of high entropy in specific parts of the body. Note that - aging is a normal anatomical and physiological process, it is not a disease.
Now you know how complex this term is?
Well, this is what Deepinder Goyal's Temple device claims to measure.
A device can produce a number without proving that the number means what its advertising says. That is the central problem with Temple’s “Entropy.”
“Entropy” has different scientific meanings. In physics, it concerns energy transformations. In heartbeat or brainwave analysis, it describes how irregular or unpredictable a signal is. Measuring one does not mean you have measured the other, or someone’s overall health.
Yes, wearable recordings can be used to calculate signal entropy. A Polar H10 chest strap, for example, records heartbeat intervals that suitable software can analyse. GE’s clinical Entropy monitor analyses electrical signals from the forehead to help assess anaesthesia. Neither tells you how much “disorder” your body contains or how long you will live.
Temple’s published research describes an optical sensor that shines light into skin and detects changes associated with blood flow. That can provide useful physiological information of flow and perfusion only there or at the heart level, but not the brain or other systems. And detecting blood-related signals does not automatically measure whole-body heat loss, metabolism or thermodynamic entropy. Those claims are wild. Extraordinary claims require extraordinary evidence.
Researchers have estimated human thermodynamic entropy production. The experiment cited by Temple used a whole-body calorimeter, measurements of breathing gases and mathematical modelling. It did not demonstrate that a small optical sensor at the temple could do the same job. Misrepresenting and misinterpreting genuine research and extrapolating that to a new device does not establish that Temple performs the measurement described in that research - this is classical Scienceploitation. It Is "sciencey" word salads. Non-medical people will fall for this sort of gimmicks.
Temple also claims that lower resting “Entropy” means better health. That is not an established universal rule. Even the theoretical paper it cites discusses the importance of maintaining adequate entropy production and increasing it when needed—not simply driving the resting value ever lower. A lower number needs a proven health meaning before it becomes a health goal. Deepinder's Science Team has to prove this first, before they let their "machine" measure it - if it really can.
A reading that changes with exercise, meals, stress or temperature may be responding to real physiology. But that does not prove it measures immune health, digestion, reproductive function or recovery. Responding to many things is not the same as understanding or measuring all those things.
Temple lists (their own) preliminary studies of heart rate and brain-circulation-related signals. Those studies do not establish the advertised health meanings of “Resting Entropy,” “Entropy Max” or “Span.” These cannot be measured using currently available wearable tech, including Temple. Combining readings into a new score does not remove the need to validate that score, or if the score is really meaningful to start with. Pretty much like Homeopathy. So much stuff, no content or context.
Highly advanced wearable science is not impossible. The problem is presenting an unvalidated interpretation as an established fact about your body. Calling a product “wellness” does not make its scientific claims true. Temple device is the commercial, expensive example of consumer scienceploitation. The website needs to be updated with medical and health truths rather than magical thinking and delusions of so-called founder and his science team.
Deepinder's Temple device is very much like Baba Ramdev's Coronil. Only one difference. Former is scienceploitation, latter is pseudoscience and both are harmful in their own ways. Learn to identify a scam and fraud when you see one.
P C Gupta retweeted
We’re BACK! 🎙️🫀
FOUR episodes featuring legends of cardiac surgery:
Dr. Albert Starr. Dr. Alain Carpentier. Dr. Denton Cooley. Dr. Donald Ross.
4 pioneers. 4 extraordinary legacies. Countless lives changed!
🎧 All four episodes out now!
surgeonsatt.buzzsprout.com/
🤖 Made with AI
P C Gupta retweeted
8 Hospitals. 3 Years. One Commitment to Nursing Excellence!
We are proud to announce that CARE Hospitals, Nampally, Hyderabad, has achieved NABH Nursing Excellence Certification, marking our remarkable journey from 2 to 8 certified hospitals in just three years. Earlier, our hospitals at Banjara Hills, HITEC City, Malakpet, and Aster Prime in Hyderabad, along with Raipur, Bhubaneswar, and Indore, had already achieved this prestigious recognition.
Under the leadership of Dr. Vincy Ashok Tribhuvan and the guidance of our Corporate Nursing Team, this milestone reflects our commitment to compassionate nursing care, quality, and patient safety.
Heartiest congratulations to our Nursing Leadership and dedicated nurses for making this achievement possible!
Together, we continue to raise the bar for Nursing Excellence!
#NABHNursingExcellence #NursingExcellence #NursingLeadership #PatientSafety #HealthcareExcellence #CAREHospitals #TransformingHealthcare
[NABH Nursing Excellence, Nursing Leadership, Patient Safety, Quality Healthcare, Nursing Excellence, CARE Hospitals]
P C Gupta retweeted
1. There is really no justification for it. The huge margins offered by drug manufacturers are due to market distortion. Manufacturers view the purchasers and prescribers, ie hospital and doctor, as their clients, not the patient on whom the medicine is used.
2. Controlling the margins on these drugs won’t affect research as claimed by manufacturers, since they are still free to fix their sale price to distributors. Only the subsequent exorbitant margin gets capped. However, corporate hospitals will certainly take a big hit and by and large their overall profit margins are not good enough to fully absorb this impact.
3. Bed charges, even in highest category of rooms, are well below the infra and running cost per bed of the hospital. It is a fact that hospitals cover the cost of stay and treatment primarily from high margins on pharmacy.
4. If margins from pharmacy and consumables too are cut off, you may find that hospitals substantially increase other charges to offset this substantial loss of income. We have seen this happen in coronary angioplasty - when margins on stents was capped, the procedure charges were increased to keep package cost the same.
5. Unfortunately in India, as of now services are not valued as much as products. Most patients are willing to pay 1 lakh for an implant, stent or medicine a lot more readily than giving the treating doctor 50k for his expertise. Additionally in oncology, the fear of cancer is a big incentive for people to spend any amount for medicines in the hope of cure. It is a sad reality that manufacturers, hospitals and doctors do exploit this situation. It is not a grand conspiracy, each of them is in it for their own reasons.
6. Even though I’m not a fan of overarching govt controls, in some situations such as this, the govt does need to step in and correct market distortions. I reiterate that for antibiotics too, rampant misuse due to high margins is causing scarily high rates of antibiotic resistance. The margins on all antibiotics must be made so low that there should be no incentive at all for misuse.
7. My opinion is that it is better for medical professionals to charge directly for services rendered, than rely on such indirect and somewhat unsavoury sources of income. People too should also get used to paying their treating doctors well for good, clean and timely services and treatment.
🚨 SUPREME COURT | “Can you show any justification for this loot?”
A cancer patient’s husband, a medical distributor, told the Supreme Court that an injection available to him at a dealer price of ₹11,000 was allegedly priced at ₹1.30 lakh by a reputed hospital, which refused to administer the injection he offered.
“Why this difference? Where does the money go?” Justice Sandeep Mehta asks the Centre.
P C Gupta retweeted
Well done @ShezanFouzdar !!
Check it out! Fouzdar and colleagues compared #thromboelastography in patients with #PAD after #bypasssurgery.
READ MORE: doi.org/10.1016/j.jvssci.202…
@AnahitaDua @harvardmed @MGHSurgery @VascularSVS
P C Gupta retweeted
In 63 patients undergoing complex pancreatic resection with extensive vascular involvement, temporary venous bypass enabled a bypass-first surgical approach, demonstrating its feasibility in selected patients with advanced pancreatic tumors. ovid.com/10.1097/SLA.0000000…
Politically loaded post. Blaming is easy. All Governments have steadfastly failed to deal with civic amenities, be it pot holes or drainage or public transportation or clean air. An exception was @ncbn as CM of united Andhra Pradesh.
ONCE UPON A TIME THERE WAS A GREAT COUNTRY CALLED INDIA.
( FIVE stupid phrases that we use that are helping destroy it).
By Sanjay Jha
My dear fellow Indians
Once upon a time, there was a great country called India. It had a glorious past, extraordinary people, limitless potential and a promising future. Frankly, it was never perfect. No country ever is. But there was hope. There was freedom. We could breathe.
Then something went horribly wrong. Of course, I am not blaming everything post-2014 alone. But the acceleration of the decline got a definitive momentum. No, it wasn’t just the politicians, albeit the bulk of the responsibility lies here. Or the bureaucrats who sold their souls. Like good ole Gyanu Ji. Or the multi-billionaires who appear to have mistaken the national assets for their family inheritance.
It was also us. Yes, you and me. All of us, in varying degrees.
We Indians have perfected five phrases that explain why a country capable of sending spacecraft to the Moon and Mars still struggles to fix a pothole on Earth. I live in Mumbai, ask me about it. We have the richest municipal corporation in the whole of Asia, by the way. Anyway, let’s cut to the chase.
Here are the five national disasters masquerading as everyday wisdom.
Read the full piece on my Substack: sanjayjhabombay.substack.com…
Nice work
💣 A Bomb in the Chest!
Not your usual post-pacemaker swelling!
A massive chest wall bulge hiding a subclavian artery pseudoaneurysm following PPI.
Covered stent to seal the leak, followed by haematoma evacuation.
#medtwitter @JVascSurgCIT @vsijournalijves @VarenyamVasc
P C Gupta retweeted
Join us for the @World_fvs session at #Veithsymposium this November @VascularGirl212 @PrajnaKota @pcvasc @Vascular_India @VascularSVS @ESVSmembership @garcia_toca @mattsmeds
What this will achieve is denial of affordable therapy to a large segment of society. There are scientific publications that show that single use material can be reused safely. It is important that such patients are not charged for reused material.
'Single-Use Medical Devices Can’t Be Reused': DGHS Bans Practice, Says Hospitals May Face Checks
"Welcoming the move, Dr Sudhir Kumar, neurologist at Apollo Hospitals, Hyderabad, said that reuse of devices labelled as single-use has been reported in some healthcare settings, often driven by cost pressures. “However, from a patient safety and regulatory perspective, reuse of devices intended for single use is difficult to justify because such devices are not designed or validated for repeated use."
"The government’s directive prohibiting the reuse of devices and surgical items that are labelled by manufacturers as “single-use" is an important patient safety measure, said Dr Kumar. “Such devices are designed, tested, and approved for only one use. Reprocessing and reusing them can increase the risk of infection, device malfunction, reduced performance, and procedure-related complications, particularly in high-risk specialities such as cardiology, neurosurgery, oncology, and cardiovascular surgery," he added.
Experts pointed to the financial side of implementation. Dr Kumar from Apollo said, “At the same time, implementation will require healthcare systems to address the financial implications of increased use of single-use devices, especially in resource-constrained settings. Policymakers, hospitals, insurers, and manufacturers should work together to ensure that safer practices do not inadvertently reduce access to essential procedures. Patient safety and affordability must go hand in hand."
An informative article prepared by @ChandnaHimani published in @CNNnews18 has my quotes, alongside that of other experts.
news18.com/india/single-use-…
P C Gupta retweeted
第79回胸部外科学会総会に出席しました。急性大動脈解離Stanford Type Aに対しての治療で上行大動脈人工血管置換術で救命を優先するのか、今後の追加治療の可能性を減じるために弓部大動脈人工血管置換術+Frozen Elephant trunk(FET)留置術まで行う方がいいのかという内容でプレゼンテーションをさせていただきました。2003年から2025年までのKACで行った2178例を対象に検討した結果、部分弓部置換術後10年でその末梢に追加治療が必要とならなかったのは76%でした。また高齢者になるほど、追加治療を必要としなかった方の割合も多くなるため、その方々にまで全例FETを入れるのは過大治療になるかもしれないという話をしました。FETは急性大動脈解離のみならず様々な場面で非常に有効で動脈瘤の治療範囲を拡大してきました。しかし物事には必ず表と裏の側面が共存するもので、私たちは日々それを考えて医療を行なっています。
とても優れたものであっても、使い方を間違えばあたかもそれが害をなしてしまうように見えてしまうこともあります。平均すると効果的に見える治療も本当にその治療が各患者にとって最適かどうかを見極めて行う必要があると思います。





























